VC  Mission BioCapital

https://www.missionbiocapital.com/





     Office Locations:

139 Main Street, Suite 401
Cambridge, MA 02142

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early


 

Industries:

  • Information Technology

  •  

    Description:

    Mission BioCapital is a VC firm making pivotal early-stage investments in biotech companies. Founded in 2009, the firm is investing out of its fifth fund. The firm's lab network can accommodate everything from the smallest company with a single lab bench all the way to teams with upwards of 30 employees. This offering of flexible lab space with top-of-the-line equipment allows entrepreneurs to streamline their infrastructure, focus on their science, and bring their novel treatments one step closer to patients. Mission BioCapital offers over 640,000 sq ft of incubator space.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Cassidy Blundell PhD Partner
    Chaya Patel PhD Principal
    Douglas Crawford PhD Managing General Partner
    Jennifer Griffin PhD Partner
    Johannes Fruehauf MD, PhD General Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      12/18/2024


      SiteOne Therapeutics


      MT


      $100,000,000


      Series C


      12/06/2024


      Nuvig Therapeutics


      CA


      $161,000,000


      Series B


      10/23/2024


      March Biosciences


      TX


      $28,400,000


      Series A


      10/03/2024


      Integrated Biosciences


      CA


      $17,200,000


      Seed


      05/22/2024


      Progentos Therapeutics


      MA


      $65,000,000


      Series A


      03/04/2024


      Nocion Therapeutics


      MA


      $62,000,000


      Series B


     

    Portfolio companies include:


      Alector


      Arkuda Therapeutics


      Atreca


      Cereius


      Dren Bio
        web link


      Fluxion


      Glycomine


      Integrated Biosciences
        web link


      Jupiter


      Kit


      March Biosciences
        web link


      Nocion Therapeutics


      Nuvig Therapeutics
        web link


      Progentos Therapeutics
        web link


      QurAlis


      Shape TX


      SiteOne Therapeutics
        web link


      Totient


      Vedere Bio II
        web link


      Volnay


      Zymergen


     

    Recent News: